Dr. Maciej L. Goniewicz assumed leadership of the Nicotine and Tobacco Product Assessment Resource (NicoTAR) Shared Resource in 2013. He determines policies and oversees operation of the NicoTAR Facility.
Dr. Goniewicz joined the staff of Roswell Park Comprehensive Cancer Center (RPCI) in 2013 and was appointed Assistant Member of the Department of Health Behavior, Division of Cancer Prevention and Population Sciences.
He earned a PharmD degree (2002) and a PhD in Toxicology and Pharmacology (2007) from the Medical University of Silesia, Poland. He completed his postdoctoral fellowships in Clinical Pharmacology and Tobacco Control at the University of California, San Francisco and in Smoking Cessation Treatment in Queen Mary University of London, UK.
Dr. Goniewicz has authored over 60 scientific papers on topics related to tobacco control, biomarkers, and nicotine-containing products. His work has been published in Tobacco Control, Nicotine and Tobacco Research, Pediatrics, Atherosclerosis, Critical Care Medicine, Chemical Research in Toxicology, Journal of Analytical Toxicology, and Cancer Epidemiology, Biomarkers, and Prevention.
Dr. Richard O’Connor has overseen operations of the Tobacco Research Laboratory, which specializes in tobacco product design characterization and its implications for use, since 2004. The laboratory is also home to the ITPR, which tracks the design and performance of cigarettes and other tobacco products in over 20 countries.
He earned a PhD in Biobehavioral Health (2004) from the Pennsylvania State University and completed a postdoctoral fellowship in health behavior and cancer prevention at Roswell Park Comprehensive Cancer Center.
Dr. O’Connor has authored over 150 scientific papers on topics related to tobacco control, product design, abuse liability, and tobacco product regulation. He has also contributed to NCI Smoking and Tobacco Control Monograph 13 (low-tar cigarettes), WHO Tob Reg reports on cigarette emissions and so called ‘fire-safe’ cigarettes, and the recent NCI/CDC monograph on global smokeless tobacco use.
Mark Travers is a Research Scientist in the Division of Cancer Prevention and Population Sciences at the Roswell Park Comprehensive Cancer Center. Mark has degrees in biomedical engineering and epidemiology and has devoted his career to providing the scientific basis for smoke-free air policies by researching exposure to tobacco smoke pollution and evaluating the effects of smoke-free air policies. He has conducted the largest study of tobacco smoke pollution exposure in the hospitality industry and his research has been featured in debates over smoke-free air legislation in dozens of communities. He has worked to provide sound scientific evidence to support smoke-free air policies and effectively communicate this evidence to researchers in a wide range of fields, national, state and local policy makers, the media, local advocacy groups and the lay public.
His current research is in validating the latest methods in air monitoring and integrating them with measurements of biological markers of exposure to tobacco smoke pollution. This research will validate and advance models of secondhand smoke exposure and risk assessment, which will hopefully serve as the new foundation on which secondhand smoke policy decisions are based. Mark and colleagues in the Roswell Park Comprehensive Cancer Center Transdisciplinary Tobacco Use Research Center are conducting a global air monitoring effort that is currently in over 40 countries around the world measuring exposures to tobacco smoke pollution and informing the debate over smoke-free air policy. Mark has trained these researchers either in-person or through his website www.tobaccofreeair.org. Mark has also trained and actively collaborated with over 60 partner organizations in 26 U.S. states and Canadian provinces in measuring tobacco smoke exposures.
Rosalie Caruso, a research technologist in the Tobacco Research Laboratory since 2007, oversees cigarette testing and product repository operations.
Noel Leigh, a research associate in RPCI’s NicoTAR laboratory since 2014, operates and maintains the facility’s GC-NPD/ GC-MSMS as well as the air liquid interface cell exposure system. He also manages the routine, day-to-day operation of the NicoTAR facility including purchasing, customer service, and billing.
Mary Palumbo, a Laboratory Technician in RPCI’s NicoTAR laboratory since 2015, operates and maintains the facility’s GC-NPD/ GC-MSMS and the associated computing systems.
Taylor Vanderbush, a Laboratory Technician in RPCI’s NicoTAR laboratory since 2016, operates and maintains the facility’s LC MS/MS and the associated computing systems.